中絶薬の世界市場レポート 2025年

中絶薬の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.3％で493億7,000万米ドルに成長します。予測期間中に予測される成長は、遠隔医療サービスの拡大、自由主義地域における政府支援の増加、女性の健康に関する新興企業への投資の増加、自己管理による人工妊娠中絶の受け入れ拡大、ヘルスケアのデジタル化の進展などによる。この期間に予想される主要動向には、ドラッグデリバリー技術の革新、デジタル配合プラットフォームの台頭、AI主導の遠隔相談ツール、中絶ケアのためのモバイルヘルスアプリケーション、中絶後のモニタリングのためのウェアラブル技術などがあります。

計画外妊娠の増加は、今後数年間の中絶薬市場の成長を促進すると予想されます。計画外妊娠とは、妊娠時に意図や計画なしに発生する妊娠のことで、多くの場合、避妊具の一貫性のない使用や誤った使用によるものです。この増加は、避妊へのアクセスが限られていることが主要原因であり、費用、教育不足、不十分なヘルスケアインフラなどの障壁が、効果的な避妊の使用を妨げています。中絶薬は、計画外の妊娠を管理するための安全で非外科的な解決策を提供し、個人の生殖に関する自律性を高め、侵襲的な処置の必要性を最小限に抑え、臨床と家庭の両方でタイムリーな医療アクセスを確保します。例えば、2022年3月、国連人口基金（UNFPA）は、世界の全妊娠の約半数、年間約1億2,100万人が計画外妊娠であると報告しました。このように、計画外の妊娠の増加が中絶薬市場の拡大に拍車をかけています。

中絶薬市場の主要企業は、患者のための手頃な価格と入手しやすさを高めるために、ヘマベートのジェネリックバージョンのような革新的な製品の開発を優先しています。ヘマベートのジェネリック医薬品は、子宮収縮を誘発するために使用されるヘマベートの先発品に代わる低コストの医薬品です。産後の出血管理に有効で、安全で効率的な薬による中絶をサポートします。例えば、米国の製薬会社であるロンググローブ・ファーマシューティカルズLLCは2022年11月、子宮アトニーによる産後出血を治療するためのより安価で入手しやすい選択肢として、Pfizer社のヘマベートのジェネリック医薬品であるカルボプロスト・トロメタミン注射剤を発売しました。この薬はまた、子宮収縮による中絶プロセスを安全に促進することで、薬による中絶においても重要な役割を果たしています。このようなジェネリック医薬品の発売は、特に先発医薬品の価格や入手可能性に課題を抱える地域において、ヘルスケアコストを削減し、必要不可欠な中絶医療へのアクセスを改善する上で重要な一歩となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の中絶薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の中絶薬市場：成長率分析
• 世界の中絶薬市場の実績：規模と成長、2019～2024年
• 世界の中絶薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の中絶薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の中絶薬市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• ミフェプリストン
• ミソプロストール
• ピトシン
• ヘマベート
• カルボプロスト
• その他
• 世界の中絶薬市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 静脈内
• 皮下
• 世界の中絶薬市場：治療用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 医療中絶
• 外科的中絶
• 世界の中絶薬市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の中絶薬市場、ミフェプリストンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ジェネリックミフェプリストン
• ブランド名ミフェプリストン
• ミソプロストールとの併用
• 世界の中絶薬市場、ミソプロストールのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口錠
• 膣錠
• 舌下錠
• バッカル錠
• 世界の中絶薬市場、ピトシンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射液
• 静脈内（IV）投与
• 筋肉内（IM）投与
• 世界の中絶薬市場、ヘマベートのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射液
• 単回投与バイアル
• マルチドーズバイアル
• 世界の中絶薬市場、カルボプロストのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 筋肉内注射
• プレフィルドシリンジ
• バイアルフォーム
• 世界の中絶薬市場、その他の薬剤クラスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• メトトレキサート
• ジノプロストン
• エルゴメトリン
• オキシトシン類似体

第7章 地域別・国別分析

• 世界の中絶薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の中絶薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 中絶薬市場：競合情勢
• 中絶薬市場：企業プロファイル
  • Pfizer Inc.
  • Bayer AG
  • Intas Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Macleods Pharmaceuticals Ltd

第31章 その他の大手企業と革新的企業

• Cipla Ltd.
• Lupin Ltd.
• Zydus Lifesciences Ltd.
• Cadila Pharmaceuticals
• Alkem Laboratories Ltd.
• Shanghai Xinhua Pharmaceutical Co. Ltd.
• Medley Pharmaceuticals
• Acme Formulations Ltd.
• Aristo Pharmaceuticals Pvt. Ltd.
• Mankind Pharma Ltd.
• Neiss Labs Ltd.
• Danco Laboratories LLC
• GenBioPro Inc.
• Exelgyn SA
• Linepharma International Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 中絶薬市場、2029年：新たな機会を提供する国
• 中絶薬市場、2029年：新たな機会を提供するセグメント
• 中絶薬市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Abortion drugs are medications that end a pregnancy by triggering a process similar to a natural miscarriage. They are generally used during the first 10 weeks of pregnancy and are approved in many countries as a safe and effective method for abortion.

The primary categories of abortion drugs include mifepristone, misoprostol, pitocin, hemabate, carboprost, among others. Mifepristone is taken orally and works by blocking the hormone progesterone, leading to the breakdown of the uterine lining and ending early pregnancy. These medications can be administered through oral, intravenous, or subcutaneous routes. They are used for therapeutic purposes such as medical and surgical abortion. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The abortion drugs market research report is one of a series of new reports from The Business Research Company that provides abortion drugs market statistics, including abortion drugs industry global market size, regional shares, competitors with an abortion drugs market share, detailed abortion drugs market segments, market trends and opportunities, and any further data you may need to thrive in the abortion drugs industry. The abortion drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The abortion drugs market size has grown rapidly in recent years. It will grow from $28.79 billion in 2024 to $32.15 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to a rise in unintended pregnancies, increased awareness of reproductive rights, higher demand for non-surgical abortion methods, population growth and urbanization, and wider availability of generic formulations.

The abortion drugs market size is expected to see rapid growth in the next few years. It will grow to $49.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The projected growth in the forecast period can be credited to the expansion of telehealth services, increased government support in liberal regions, rising investment in women's health startups, growing acceptance of self-managed abortions, and the advancement of healthcare digitization. Key trends expected during this period include innovations in drug delivery technologies, the rise of digital prescription platforms, AI-driven teleconsultation tools, mobile health applications for abortion care, and wearable technology for post-abortion monitoring.

The increasing occurrence of unplanned pregnancies is expected to drive the growth of the abortion drug market in the coming years. Unplanned pregnancies are those that occur without intent or planning at the time of conception, often due to inconsistent or incorrect use of contraceptives. This rise is largely attributed to limited access to contraception, with barriers such as cost, lack of education, and insufficient healthcare infrastructure hindering effective birth control use. Abortion drugs offer a safe, non-surgical solution to manage unplanned pregnancies, empowering individuals with greater reproductive autonomy, minimizing the need for invasive procedures, and ensuring timely healthcare access both in clinical and home settings. For example, in March 2022, the United Nations Population Fund (UNFPA) reported that nearly half of all pregnancies worldwide, around 121 million annually, are unplanned. Thus, the growing number of unplanned pregnancies is fueling the expansion of the abortion drug market.

Leading companies in the abortion drug market are prioritizing the development of innovative products, such as generic versions of hemabate, to enhance affordability and accessibility for patients. Generic hemabate is a lower-cost alternative to the original Hemabate drug, used to induce uterine contractions. It is effective in managing postpartum bleeding and supports safe and efficient medical abortions. For example, in November 2022, Long Grove Pharmaceuticals LLC, a US-based pharmaceutical company, introduced carboprost tromethamine injection, the generic equivalent of Pfizer's Hemabate, as a more affordable and accessible option for treating postpartum hemorrhage caused by uterine atony. This medication also plays a vital role in medical abortion by safely facilitating the termination process through uterine contractions. The launch of such generic alternatives marks an important step in reducing healthcare costs and improving access to essential abortion care, particularly in regions facing challenges with the affordability and availability of branded medications.

In March 2024, CVS Health Corp, a US-based pharmacy company, partnered with Walgreens Boots Alliance Inc. to start offering the abortion pill mifepristone in stores across various states. Through this collaboration, CVS and Walgreens seek to expand access to reproductive healthcare by making the medication available at numerous retail locations, thereby supporting women's right to choose amid increasing legal limitations on abortion. Walgreens Boots Alliance Inc. is a US-based retail company that delivers pharmacy, health, and wellness products and services through its broad store network.

Major players in the abortion drugs market are Pfizer Inc., Bayer AG, Intas Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd, Cipla Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Cadila Pharmaceuticals, Alkem Laboratories Ltd., Shanghai Xinhua Pharmaceutical Co. Ltd., Medley Pharmaceuticals, Acme Formulations Ltd., Aristo Pharmaceuticals Pvt. Ltd., Mankind Pharma Ltd., Neiss Labs Ltd., Danco Laboratories LLC, GenBioPro Inc., Exelgyn SA, Linepharma International Limited, Adorshea.

North America was the largest region in the abortion drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in abortion drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the abortion drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The abortion drugs market consists of sales of prostaglandin analogs, anti-progestogens, anti-progestogens, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics and sedatives. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Abortion Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on abortion drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for abortion drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The abortion drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Mifepristone ; Misoprostol ; Pitocin; Hemabate; Carboprost; Other Drug Classes
• 2) By Route Of Administration: Oral; Intravenous; Subcutaneous
• 3) By Therapeutic Application: Medical Abortion; Surgical Abortion
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Mifepristone: Generic Mifepristone; Branded Mifepristone; Combination With Misoprostol
• 2) By Misoprostol: Oral Tablets; Vaginal Tablets; Sublingual Tablets; Buccal Tablets
• 3) By Pitocin: Injectable Solution; Intravenous (IV) Administration; Intramuscular (IM) Administration
• 4) By Hemabate: Injectable Solution; Single-Dose Vials; Multi-Dose Vials
• 5) By Carboprost: Intramuscular Injection; Prefilled Syringes; Vial Form
• 6) By Other Drug Classes: Methotrexate; Dinoprostone; Ergometrine; Oxytocin Analogs
• Companies Mentioned: Pfizer Inc.; Bayer AG; Intas Pharmaceuticals; Sun Pharmaceutical Industries Ltd.; Macleods Pharmaceuticals Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Abortion Drugs Market Characteristics

3. Abortion Drugs Market Trends And Strategies

4. Abortion Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Abortion Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Abortion Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Abortion Drugs Market Growth Rate Analysis
• 5.4. Global Abortion Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Abortion Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Abortion Drugs Total Addressable Market (TAM)

6. Abortion Drugs Market Segmentation

• 6.1. Global Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mifepristone
• Misoprostol
• Pitocin
• Hemabate
• Carboprost
• Other Drug Classes
• 6.2. Global Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.3. Global Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Abortion
• Surgical Abortion
• 6.4. Global Abortion Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Abortion Drugs Market, Sub-Segmentation Of Mifepristone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generic Mifepristone
• Branded Mifepristone
• Combination With Misoprostol
• 6.6. Global Abortion Drugs Market, Sub-Segmentation Of Misoprostol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Vaginal Tablets
• Sublingual Tablets
• Buccal Tablets
• 6.7. Global Abortion Drugs Market, Sub-Segmentation Of Pitocin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Solution
• Intravenous (IV) Administration
• Intramuscular (IM) Administration
• 6.8. Global Abortion Drugs Market, Sub-Segmentation Of Hemabate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Solution
• Single-Dose Vials
• Multi-Dose Vials
• 6.9. Global Abortion Drugs Market, Sub-Segmentation Of Carboprost, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular Injection
• Prefilled Syringes
• Vial Form
• 6.10. Global Abortion Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methotrexate
• Dinoprostone
• Ergometrine
• Oxytocin Analogs

7. Abortion Drugs Market Regional And Country Analysis

• 7.1. Global Abortion Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Abortion Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Abortion Drugs Market

• 8.1. Asia-Pacific Abortion Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Abortion Drugs Market

• 9.1. China Abortion Drugs Market Overview
• 9.2. China Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Abortion Drugs Market

• 10.1. India Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Abortion Drugs Market

• 11.1. Japan Abortion Drugs Market Overview
• 11.2. Japan Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Abortion Drugs Market

• 12.1. Australia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Abortion Drugs Market

• 13.1. Indonesia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Abortion Drugs Market

• 14.1. South Korea Abortion Drugs Market Overview
• 14.2. South Korea Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Abortion Drugs Market

• 15.1. Western Europe Abortion Drugs Market Overview
• 15.2. Western Europe Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Abortion Drugs Market

• 16.1. UK Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Abortion Drugs Market

• 17.1. Germany Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Abortion Drugs Market

• 18.1. France Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Abortion Drugs Market

• 19.1. Italy Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Abortion Drugs Market

• 20.1. Spain Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Abortion Drugs Market

• 21.1. Eastern Europe Abortion Drugs Market Overview
• 21.2. Eastern Europe Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Abortion Drugs Market

• 22.1. Russia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Abortion Drugs Market

• 23.1. North America Abortion Drugs Market Overview
• 23.2. North America Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Abortion Drugs Market

• 24.1. USA Abortion Drugs Market Overview
• 24.2. USA Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Abortion Drugs Market

• 25.1. Canada Abortion Drugs Market Overview
• 25.2. Canada Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Abortion Drugs Market

• 26.1. South America Abortion Drugs Market Overview
• 26.2. South America Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Abortion Drugs Market

• 27.1. Brazil Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Abortion Drugs Market

• 28.1. Middle East Abortion Drugs Market Overview
• 28.2. Middle East Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Abortion Drugs Market

• 29.1. Africa Abortion Drugs Market Overview
• 29.2. Africa Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Abortion Drugs Market Competitive Landscape And Company Profiles

• 30.1. Abortion Drugs Market Competitive Landscape
• 30.2. Abortion Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Intas Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Macleods Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Abortion Drugs Market Other Major And Innovative Companies

• 31.1. Cipla Ltd.
• 31.2. Lupin Ltd.
• 31.3. Zydus Lifesciences Ltd.
• 31.4. Cadila Pharmaceuticals
• 31.5. Alkem Laboratories Ltd.
• 31.6. Shanghai Xinhua Pharmaceutical Co. Ltd.
• 31.7. Medley Pharmaceuticals
• 31.8. Acme Formulations Ltd.
• 31.9. Aristo Pharmaceuticals Pvt. Ltd.
• 31.10. Mankind Pharma Ltd.
• 31.11. Neiss Labs Ltd.
• 31.12. Danco Laboratories LLC
• 31.13. GenBioPro Inc.
• 31.14. Exelgyn SA
• 31.15. Linepharma International Limited

32. Global Abortion Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Abortion Drugs Market

34. Recent Developments In The Abortion Drugs Market

35. Abortion Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Abortion Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Abortion Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Abortion Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer